<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Little is known about disparities in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We performed a retrospective chart review of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 252) evaluated at the University of Maryland Greenebaum <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center between 2000 and 2010 </plain></SENT>
<SENT sid="2" pm="."><plain>The median age at diagnosis was 65 years, which was lower than the median age of 76 years for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in the Surveillance, Epidemiology and End Results database </plain></SENT>
<SENT sid="3" pm="."><plain>Black males were younger than white males (62 vs. 68 years; p = 0.03) and had longer time to referral (9 vs. 1.5 months; p = 0.03), but black and white females did not differ in age or in time to referral </plain></SENT>
<SENT sid="4" pm="."><plain>A difference in World Health Organization subtype classification was noted in black and white patients at diagnosis, but not at referral </plain></SENT>
<SENT sid="5" pm="."><plain>There was no difference between <z:hpo ids='HP_0000001'>all</z:hpo> other pretreatment characteristics, treatment and survival by race </plain></SENT>
<SENT sid="6" pm="."><plain>Our data suggest barriers to tertiary care referral for older patients and for black males </plain></SENT>
</text></document>